Star Health Reports Strong Q2 Profit, Supports Irdai Expense Cap Reforms
Star Health reported a strong Q2 FY27 performance with net profit rising to around Rs 260 crore, driven by improved claims ratio and underwriting profit. The company supports Irdai's proposed expense cap reforms but requests exclusion of regulation-mandated products like motor third-party insurance from expense calculations. Analysts from Nomura, Emkay Global, and Motilal Oswal maintain buy ratings, noting better-than-expected core profitability and cautious optimism on premium growth moderating in the second half of the fiscal year.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (70/100). Lens Score 42/100.
Outlets measured: moneycontrol, moneycontrol, moneycontrol, mint. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (68–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
mint broke this story on 28 Oct, 12:10 pm. Other outlets followed.